Chemoembolization agents
US12357570B2 · kind B2 · utility
0Cited by
15References
18Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 19, 2023 |
| Grant date | Jul 15, 2025 |
| Priority date | — |
| Expiry date | Jun 19, 2043 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein is a chemoembolization therapy, which combines therapeutic effects of peripheral arterial occlusion with the local administration of an anti-cancer agent. A particle or microsphere occludes the arteries providing blood flow to the tumor, resulting in tumor oxygen deprivation. The anti-angiogenic agent is an anti-cancer drug, as described herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.